Literature DB >> 10529206

Critical residues influence the affinity and selectivity of alpha-conotoxin MI for nicotinic acetylcholine receptors.

R B Jacobsen1, R G DelaCruz, J H Grose, J M McIntosh, D Yoshikami, B M Olivera.   

Abstract

The mammalian skeletal muscle acetylcholine receptor contains two nonequivalent acetylcholine binding sites, one each at the alpha/delta and alpha/gamma subunit interfaces. Alpha-Conotoxin MI, a 14-amino acid competitive antagonist, binds at both interfaces but has approximately 10(4) higher affinity for the alpha/delta site. We performed an "alanine walk" to identify the residues in alpha-MI that contribute to this selective interaction with the alpha/delta site. Electrophysiological measurements with Xenopus oocytes expressing normal receptors or receptors lacking either the gamma or delta subunit were made to assay toxin-receptor interaction. Alanine substitutions in most amino acid positions had only modest effects on toxin potency at either binding site. However, substitutions in two positions, proline-6 and tyrosine-12, dramatically reduced toxin potency at the high-affinity alpha/delta site while having comparatively little effect on low-affinity alpha/gamma binding. When tyrosine-12 was replaced by alanine, the toxin's selectivity for the high-affinity site (relative to that for the low-affinity site) was reduced from 45,000- to 30-fold. A series of additional amino acid substitutions in this position showed that increasing side chain size/hydrophobicity increases toxin potency at the alpha/delta site without affecting alpha/gamma binding. In contrast, when tyrosine-12 is diiodinated, toxin binding is nearly irreversible at the alpha/delta site but also increases by approximately 500-fold at the alpha/gamma site. The effects of position 12 substitutions are accounted for almost entirely by changes in the rate of toxin dissociation from the high-affinity alpha/delta binding site.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529206     DOI: 10.1021/bi9907476

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  A comparative study on selectivity of alpha-conotoxins GI and ImI using their synthetic analogues and derivatives.

Authors:  Igor E Kasheverov; Maxim N Zhmak; Innokenty V Maslennikov; Yuri N Utkin; Victor I Tsetlin
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

2.  Neuromuscular effects of candoxin, a novel toxin from the venom of the Malayan krait (Bungarus candidus).

Authors:  S Nirthanan; E Charpantier; P Gopalakrishnakone; M C E Gwee; H E Khoo; L S Cheah; R M Kini; D Bertrand
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

3.  Rational design of alpha-conotoxin analogues targeting alpha7 nicotinic acetylcholine receptors: improved antagonistic activity by incorporation of proline derivatives.

Authors:  Christopher Armishaw; Anders A Jensen; Thomas Balle; Richard J Clark; Kasper Harpsøe; Christian Skonberg; Tommy Liljefors; Kristian Strømgaard
Journal:  J Biol Chem       Date:  2009-01-08       Impact factor: 5.157

4.  A novel α4/7-conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors.

Authors:  Sulan Luo; Dongting Zhangsun; Christina I Schroeder; Xiaopeng Zhu; Yuanyan Hu; Yong Wu; Maegan M Weltzin; Spencer Eberhard; Quentin Kaas; David J Craik; J Michael McIntosh; Paul Whiteaker
Journal:  FASEB J       Date:  2014-01-07       Impact factor: 5.191

Review 5.  Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.

Authors:  Layla Azam; J Michael McIntosh
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

6.  α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells.

Authors:  Arik J Hone; J Michael McIntosh; Layla Azam; Jon Lindstrom; Linda Lucero; Paul Whiteaker; Juan Passas; Jesús Blázquez; Almudena Albillos
Journal:  Mol Pharmacol       Date:  2015-09-01       Impact factor: 4.436

Review 7.  Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads.

Authors:  Christopher J Armishaw
Journal:  Toxins (Basel)       Date:  2010-06-14       Impact factor: 4.546

8.  Structural and Functional Characterization of a Novel α-Conotoxin Mr1.7 from Conus marmoreus Targeting Neuronal nAChR α3β2, α9α10 and α6/α3β2β3 Subtypes.

Authors:  Shuo Wang; Cong Zhao; Zhuguo Liu; Xuesong Wang; Na Liu; Weihong Du; Qiuyun Dai
Journal:  Mar Drugs       Date:  2015-05-27       Impact factor: 5.118

Review 9.  Conotoxins targeting nicotinic acetylcholine receptors: an overview.

Authors:  Eline K M Lebbe; Steve Peigneur; Isuru Wijesekara; Jan Tytgat
Journal:  Mar Drugs       Date:  2014-05-22       Impact factor: 5.118

Review 10.  Venom-Derived Neurotoxins Targeting Nicotinic Acetylcholine Receptors.

Authors:  Ayaulym Bekbossynova; Albina Zharylgap; Olena Filchakova
Journal:  Molecules       Date:  2021-06-03       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.